twit 25   linkedin 25

16 / May 10

NewCap accompanied the first two Health-sector IPOs in 2016

In the first half of 2016, NewCap accompanied the first two Health-sector IPOs in France:

GeNeuro, a Swiss biopharmaceutical company developing new treatments for autoimmune diseases including multiple sclerosis, has completed its initial public offering on compartment B of Euronext's regulated market in Paris by way of an initial public offering in France and an international offering to institutional investors both inside or outside France and raised €33 million.

Asit Biotech, a Belgian clinical stage biopharmaceutical company focused on the research, development and future commercialisation of a range of breakthrough immunotherapy products for the treatment of allergies, raised 23,5M€ through its IPO on the regulated markets of Euronext Brussels and Euronext Paris.

About NewCap

As a specialist in investor relations and strategic communication advice, NewCap advises and supports its clients regarding their sectoral, scientific, institutional and financial communication strategies.

CONTACT

contact 01Address :
21, place de la Madeleine - 75008 Paris

contact 02Phone :
+33 (0)1 44 71 94 94

contact 03Email :
infos(at)newcap.fr